Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 533

1.

Results of Tri-Modality Therapy for Rectal Cancer in Elderly Patients.

Treder M, Janssen S, Schild SE, Rades D.

Anticancer Res. 2019 Nov;39(11):6217-6222. doi: 10.21873/anticanres.13830.

PMID:
31704850
2.

A randomized double-blind phase II study of the Seneca Valley Virus (NTX-010) vs placebo for patients with extensive stage SCLC (ES-SCLC) who were stable or responding after at least 4 cycles of platinum-based chemotherapy: NCCTG (Alliance) N0923 Study.

Schenk EL, Mandrekar SJ, Dy GK, Aubry MC, Tan AD, Dakhil SR, Sachs BA, Nieva JJ, Bertino E, Lee Hann C, Schild SE, Wadsworth TW, Adjei AA, Molina JR.

J Thorac Oncol. 2019 Oct 9. pii: S1556-0864(19)33411-2. doi: 10.1016/j.jtho.2019.09.083. [Epub ahead of print]

PMID:
31605793
3.

Rational Radiotherapy: The Role in Node-negative Squamous Cell Carcinoma.

Yu NY, Patel SH, Schild SE, DeWees TA.

J Am Acad Dermatol. 2019 Oct 4. pii: S0190-9622(19)32811-7. doi: 10.1016/j.jaad.2019.09.062. [Epub ahead of print] No abstract available.

PMID:
31589942
4.

Characterization of Vibrio cholerae's Extracellular Nuclease Xds.

Pressler K, Mitterer F, Vorkapic D, Reidl J, Oberer M, Schild S.

Front Microbiol. 2019 Sep 10;10:2057. doi: 10.3389/fmicb.2019.02057. eCollection 2019.

5.

Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).

Liu C, Yu NY, Shan J, Bhangoo RS, Daniels TB, Chiang JS, Ding X, Lara P, Patrick CL, Archuleta JP, DeWees T, Hu Y, Schild SE, Bues M, Sio TT, Liu W.

Med Phys. 2019 Nov;46(11):4755-4762. doi: 10.1002/mp.13809. Epub 2019 Sep 21.

PMID:
31498885
6.

The Search for Optimal Stereotactic Body Radiotherapy Dose in Inoperable, Centrally Located Non-Small-Cell Lung Cancer Continues.

Sio TT, Mohindra P, Yu NY, Ashman JB, Daniels TB, Merrell KW, Schild SE.

J Clin Oncol. 2019 Oct 10;37(29):2697-2699. doi: 10.1200/JCO.19.01330. Epub 2019 Aug 29. No abstract available.

PMID:
31465261
7.

Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysis.

Chow R, Hoskin P, Schild SE, Raman S, Im J, Zhang D, Chan S, Chiu N, Chiu L, Lam H, Chow E, Lock M.

Radiother Oncol. 2019 Aug 21. pii: S0167-8140(19)32978-0. doi: 10.1016/j.radonc.2019.06.037. [Epub ahead of print]

PMID:
31445837
8.

Trends of maxillofacial trauma: An update from the prospective register of a multicenter study in emergency services of Chile.

Werlinger F, Villalón M, Duarte V, Acevedo R, Aguilera R, Alcocer D, Badillo O, Briones R, Condal C, Del Río M, García R, Herrera M, Jaramillo J, Merchan F, Nasi M, Osbén R, Rivera A, Riviello S, Rojas P, Vidal C, Rodríguez G, Schild S, Arroyo E, Alvarado MJ, Sepúlveda P, Cortés J.

Med Oral Patol Oral Cir Bucal. 2019 Sep 1;24(5):e588-e594. doi: 10.4317/medoral.22985.

9.

A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN).

Rades D, Narvaez CA, Splettstößer L, Dömer C, Setter C, Idel C, Ribbat-Idel J, Perner S, Bartscht T, Olbrich D, Schild SE, Carl J.

Radiother Oncol. 2019 Oct;139:79-82. doi: 10.1016/j.radonc.2019.07.023. Epub 2019 Aug 17.

PMID:
31431372
10.

Patient-Reported Outcomes-Secondary Analysis of the SCORE-2 Trial Comparing 4 Gy × 5 to 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression.

Rades D, Šegedin B, Conde-Moreno AJ, Ferrer-Albiach C, Metz M, Polat B, Badakhshi H, Schreiber A, Nitsche M, Cacicedo J, Schild SE.

Int J Radiat Oncol Biol Phys. 2019 Nov 15;105(4):760-764. doi: 10.1016/j.ijrobp.2019.08.002. Epub 2019 Aug 12.

PMID:
31415797
11.

Prognostic Role of Pre-Treatment Symptoms for Survival of Patients Irradiated for Brain Metastases.

Rades D, Hansen HC, Dziggel L, Janssen S, Schild SE.

Anticancer Res. 2019 Aug;39(8):4273-4277. doi: 10.21873/anticanres.13591.

PMID:
31366517
12.

Regulated Proteolysis in Vibrio cholerae Allowing Rapid Adaptation to Stress Conditions.

Pennetzdorfer N, Lembke M, Pressler K, Matson JS, Reidl J, Schild S.

Front Cell Infect Microbiol. 2019 Jun 21;9:214. doi: 10.3389/fcimb.2019.00214. eCollection 2019. Review.

13.

Time to Change the Limited-Stage Paradigm for Small Cell Lung Cancer?

Chun SG, Schild SE, Bogart JA.

JAMA Oncol. 2019 Jun 20. doi: 10.1001/jamaoncol.2019.1326. [Epub ahead of print] No abstract available.

PMID:
31219511
14.

Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protons.

Kang Y, Shen J, Liu W, Taylor PA, Mehrens HS, Ding X, Hu Y, Tryggestad E, Keole SR, Schild SE, Wong WW, Fatyga M, Bues M.

Radiat Oncol. 2019 Jun 17;14(1):108. doi: 10.1186/s13014-019-1316-y.

15.

Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer.

Rades D, Motisi L, Veninga T, Conde-Moreno A, Cacicedo J, Schild SE.

Clin Lung Cancer. 2019 Jul;20(4):322-329. doi: 10.1016/j.cllc.2019.04.005. Epub 2019 Apr 26.

PMID:
31155476
16.

Small-cell Lung Cancer in Very Elderly (≥ 80 Years) Patients.

Schild SE, Zhao L, Wampfler JA, Daniels TB, Sio T, Ross HJ, Paripati H, Marks RS, Yi J, Liu H, He Y, Yang P.

Clin Lung Cancer. 2019 Jul;20(4):313-321. doi: 10.1016/j.cllc.2019.05.007. Epub 2019 May 11.

PMID:
31155475
17.

A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort.

Janssen S, Hansen HC, Dziggel L, Schild SE, Rades D.

Radiol Oncol. 2019 May 8;53(2):219-224. doi: 10.2478/raon-2019-0020.

18.

Diagnosis-specific WBRT-30-CRC Score for Estimating Survival of Patients Irradiated for Brain Metastases from Colorectal Cancer.

Rades D, Hansen HC, Janssen S, Schild SE.

Anticancer Res. 2019 May;39(5):2569-2574. doi: 10.21873/anticanres.13379.

PMID:
31092454
19.

A Digital Cognitive Aid for Anesthesia to Support Intraoperative Crisis Management: Results of the User-Centered Design Process.

Schild S, Sedlmayr B, Schumacher AK, Sedlmayr M, Prokosch HU, St Pierre M; German Cognitive Aid Working Group.

JMIR Mhealth Uhealth. 2019 Apr 29;7(4):e13226. doi: 10.2196/13226.

20.

Estimating Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Whole-brain Radiotherapy With a New Tool.

Hansen HC, Janssen S, Schild SE, Rades D.

Anticancer Res. 2019 Apr;39(4):2091-2095. doi: 10.21873/anticanres.13321.

PMID:
30952754
21.

Evaluation of a Patient-Facing Digital Prototype for Perioperative Risk Assessment.

Mang J, Schild S, Prokosch HU, Jeleazcov C, Heinrich A, Toddenroth D.

Stud Health Technol Inform. 2019;258:201-205.

PMID:
30942746
22.

A New Diagnosis-Specific Survival Score for Patients to be Irradiated for Brain Metastases from Non-small Cell Lung Cancer.

Rades D, Hansen HC, Schild SE, Janssen S.

Lung. 2019 Jun;197(3):321-326. doi: 10.1007/s00408-019-00223-6. Epub 2019 Mar 29.

PMID:
30927058
23.

Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM.

Rades D, Sehmisch L, Hansen HC, Dziggel L, Janssen S, Schild SE.

Anticancer Res. 2019 Mar;39(3):1501-1505. doi: 10.21873/anticanres.13268.

PMID:
30842188
24.

Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses.

Hansen HC, Janssen S, Thieme C, Perlov A, Schild SE, Rades D.

Anticancer Res. 2019 Mar;39(3):1343-1346. doi: 10.21873/anticanres.13247.

PMID:
30842167
25.

Klebsiella oxytoca enterotoxins tilimycin and tilivalline have distinct host DNA-damaging and microtubule-stabilizing activities.

Unterhauser K, Pöltl L, Schneditz G, Kienesberger S, Glabonjat RA, Kitsera M, Pletz J, Josa-Prado F, Dornisch E, Lembacher-Fadum C, Roier S, Gorkiewicz G, Lucena D, Barasoain I, Kroutil W, Wiedner M, Loizou JI, Breinbauer R, Díaz JF, Schild S, Högenauer C, Zechner EL.

Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3774-3783. doi: 10.1073/pnas.1819154116. Epub 2019 Feb 11.

26.

Comparison of Diagnosis-Specific Survival Scores for Patients with Small-Cell Lung Cancer Irradiated for Brain Metastases.

Rades D, Hansen HC, Janssen S, Schild SE.

Cancers (Basel). 2019 Feb 16;11(2). pii: E233. doi: 10.3390/cancers11020233.

27.

Modeling of Acute Rectal Toxicity to Compare Two Patient Positioning Methods for Prostate Cancer Radiotherapy: Can Toxicity Modeling be Used for Quality Assurance?

Liu X, Li J, Schild SE, Schild MH, Wong W, Vora S, Herman MG, Fatyga M.

OMICS J Radiol. 2018;7(5). pii: 302. doi: 10.4172/2167-7964.1000302. Epub 2018 Dec 3.

28.

A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression.

Rades D, Conde-Moreno AJ, Cacicedo J, Veninga T, Segedin B, Stanic K, Schild SE.

Radiat Oncol. 2018 Dec 29;13(1):257. doi: 10.1186/s13014-018-1203-y.

29.

Outcomes After Radiotherapy Alone for Metastatic Spinal Cord Compression in Patients with Oligo-metastatic Breast Cancer.

Rades D, Panzner A, Janssen S, Dunst J, Veninga T, Holländer NH, Schild SE.

Anticancer Res. 2018 Dec;38(12):6897-6903. doi: 10.21873/anticanres.13066.

PMID:
30504407
30.

A Matched-Pair Study Comparing Surgery Plus Neoadjuvant Radio-Chemotherapy and Surgery Alone for High Rectal Cancers.

Rades D, Vogelsang RP, Treder M, Janssen S, Schild SE, Holländer NH, Gögenur I.

Anticancer Res. 2018 Dec;38(12):6877-6880. doi: 10.21873/anticanres.13063.

PMID:
30504404
31.

Prognostic Factors and a Survival Score in Patients Irradiated for Metastatic Epidural Spinal Cord Compression from Urothelial Carcinoma Cancer of the Bladder.

Rades D, Sondermann L, Motisi L, Janssen S, Cacicedo J, Schild SE.

Anticancer Res. 2018 Dec;38(12):6841-6846. doi: 10.21873/anticanres.13058.

PMID:
30504399
32.

Whole-Brain Radiotherapy (WBRT) for Brain Metastases: Does the Interval Between Imaging and Treatment Matter?

Hansen HC, Janssen S, Thieme C, Perlov A, Schild SE, Rades D.

Anticancer Res. 2018 Dec;38(12):6835-6840. doi: 10.21873/anticanres.13057.

PMID:
30504398
33.

Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial.

Sio TT, Atherton PJ, Pederson LD, Zhen WK, Mutter RW, Garces YI, Ma DJ, Leenstra JL, Rwigema JM, Dakhil S, Bearden JD, van der Veen SJ, Ganti AK, Schild SE, Miller RC.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):686-696. doi: 10.1016/j.ijrobp.2018.10.035. Epub 2018 Nov 2.

34.

A novel and individualized robust optimization method using normalized dose interval volume constraints (NDIVC) for intensity-modulated proton radiotherapy.

Shan J, Sio TT, Liu C, Schild SE, Bues M, Liu W.

Med Phys. 2019 Jan;46(1):382-393. doi: 10.1002/mp.13276. Epub 2018 Nov 30.

PMID:
30387870
35.

A prospective clinical study to evaluate the performance of zirconium dioxide dental implants in single-tooth edentulous area: 3-year follow-up.

Bormann KH, Gellrich NC, Kniha H, Schild S, Weingart D, Gahlert M.

BMC Oral Health. 2018 Nov 1;18(1):181. doi: 10.1186/s12903-018-0636-x.

36.

Radiation and the heart: systematic review of dosimetry and cardiac endpoints.

Niska JR, Thorpe CS, Allen SM, Daniels TB, Rule WG, Schild SE, Vargas CE, Mookadam F.

Expert Rev Cardiovasc Ther. 2018 Dec;16(12):931-950. doi: 10.1080/14779072.2018.1538785. Epub 2018 Nov 1.

PMID:
30360659
37.

Potential Prognostic Factors of Downstaging Following Preoperative Chemoradiation for High Rectal Cancer.

Treder M, Vogelsang RP, Janssen S, Schild SE, Holländer NH, Rades D.

In Vivo. 2018 Nov-Dec;32(6):1481-1484. doi: 10.21873/invivo.11403.

38.

A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients.

Stinchcombe TE, Fan W, Schild SE, Vokes EE, Bogart J, Le QT, Thomas CR, Edelman MJ, Horn L, Komaki R, Cohen HJ, Kishor Ganti A, Pang H, Wang X.

Cancer. 2019 Feb 1;125(3):382-390. doi: 10.1002/cncr.31813. Epub 2018 Oct 21.

PMID:
30343497
39.

Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.

Liu C, Sio TT, Deng W, Shan J, Daniels TB, Rule WG, Lara PR, Korte SM, Shen J, Ding X, Schild SE, Bues M, Liu W.

J Appl Clin Med Phys. 2018 Nov;19(6):140-148. doi: 10.1002/acm2.12459. Epub 2018 Oct 17.

40.

Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer.

Schild SE, Fan W, Stinchcombe TE, Vokes EE, Ramalingam SS, Bradley JD, Kelly K, Pang HH, Wang X.

J Thorac Oncol. 2019 Feb;14(2):298-303. doi: 10.1016/j.jtho.2018.09.021. Epub 2018 Oct 4.

PMID:
30292852
41.

Comparative analyses of biofilm formation among different Cutibacterium acnes isolates.

Kuehnast T, Cakar F, Weinhäupl T, Pilz A, Selak S, Schmidt MA, Rüter C, Schild S.

Int J Med Microbiol. 2018 Dec;308(8):1027-1035. doi: 10.1016/j.ijmm.2018.09.005. Epub 2018 Sep 22.

42.

Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic Experience.

Hobbs CJ, Ko SJ, Paryani NN, Accurso JM, Olivier KR, Garces YI, Park SS, Hallemeier CL, Schild SE, Vora SA, Ashman JB, Rule WG, Bowers JR, Heckman MG, Diehl NN, Miller RC.

Mayo Clin Proc Innov Qual Outcomes. 2017 Dec 26;2(1):40-48. doi: 10.1016/j.mayocpiqo.2017.11.001. eCollection 2018 Mar.

43.

Proteolysis of ToxR is controlled by cysteine-thiol redox state and bile salts in Vibrio cholerae.

Lembke M, Pennetzdorfer N, Tutz S, Koller M, Vorkapic D, Zhu J, Schild S, Reidl J.

Mol Microbiol. 2018 Dec;110(5):796-810. doi: 10.1111/mmi.14125. Epub 2018 Oct 25.

44.

Role of Neoadjuvant Radio-chemotherapy for the Treatment of High Rectal Cancer.

Treder M, Janssen S, Holländer NH, Schild SE, Rades D.

Anticancer Res. 2018 Sep;38(9):5371-5377. doi: 10.21873/anticanres.12866.

PMID:
30194191
45.

Does hut climate matter for piglet survival in organic production?

Schild SA, Foldager L, Bonde MK, Andersen HM, Pedersen LJ.

Animal. 2019 Apr;13(4):826-834. doi: 10.1017/S175173111800201X. Epub 2018 Aug 16.

PMID:
30113279
46.

Silence is golden: gene silencing of V. cholerae during intestinal colonization delivers new aspects to the acid tolerance response.

Cakar F, Zingl FG, Schild S.

Gut Microbes. 2019;10(2):228-234. doi: 10.1080/19490976.2018.1502538. Epub 2018 Aug 15.

47.

Isolation of Outer Membrane Vesicles Including Their Quantitative and Qualitative Analyses.

Kohl P, Zingl FG, Eichmann TO, Schild S.

Methods Mol Biol. 2018;1839:117-134. doi: 10.1007/978-1-4939-8685-9_11.

PMID:
30047059
48.

Stereotactic body radiotherapy for early-stage non-small cell lung cancer has low post-treatment mortality.

Niska JR, Sio TT, Daniels TB, Beamer SE, Jaroszewski DE, Ross HJ, Paripati HR, Schild SE.

J Thorac Dis. 2018 Jun;10(Suppl 17):S2004-S2006. doi: 10.21037/jtd.2018.04.169. No abstract available.

49.

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.

Ettinger DS, Aisner DL, Wood DE, Akerley W, Bauman J, Chang JY, Chirieac LR, D'Amico TA, Dilling TJ, Dobelbower M, Govindan R, Gubens MA, Hennon M, Horn L, Lackner RP, Lanuti M, Leal TA, Lilenbaum R, Lin J, Loo BW, Martins R, Otterson GA, Patel SP, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M.

J Natl Compr Canc Netw. 2018 Jul;16(7):807-821. doi: 10.6004/jnccn.2018.0062.

PMID:
30006423
50.

A Tool to Predict the Probability of Intracerebral Recurrence or New Cerebral Metastases After Whole-brain Irradiation in Patients with Head-and-Neck Cancer.

Staackmann C, Janssen S, Schild SE, Rades D.

Anticancer Res. 2018 Jul;38(7):4199-4202. doi: 10.21873/anticanres.12714.

PMID:
29970550

Supplemental Content

Loading ...
Support Center